The Pennsylvania Senate passed Senate Bill 717 (SB717) on July 12, 2026, in a 41–9 vote, advancing what would be the most significant change to nurse practitioner scope of practice in the state in decades. The bill now moves to the Pennsylvania House of Representatives, where the Pennsylvania Coalition of Nurse Practitioners has continued to build support for passage.

Pennsylvania has long been classified among the country’s most restrictive states for nurse practitioner practice. Under current law, NPs in Pennsylvania must maintain a written collaborative agreement with a physician in order to practice and prescribe. That requirement has limited independent NP clinic openings, constrained prescribing flexibility, and created administrative overhead that other states in the region have already eliminated. New York granted full practice authority to experienced NPs in 2022 and just extended those provisions through 2030 (effective this month). Maryland expanded NP practice authority several years ago. Delaware and New Jersey both operate under full practice frameworks. Pennsylvania remained the outlier in the Mid-Atlantic.

What SB717 Would Change

SB717 amends Pennsylvania’s Professional Nursing Law to modernize the definitions and licensure framework for certified nurse practitioners. The bill’s core change is eliminating the mandatory physician collaborative agreement requirement for qualified NPs—the same requirement that full-practice-authority states have removed as the standard pathway to independent APRN practice.

Under SB717 as passed by the Senate, Pennsylvania NPs who meet a threshold of clinical hours and experience would be permitted to:

  • Evaluate patients and diagnose independently without requiring a physician co-signature
  • Order and interpret diagnostic tests independently
  • Initiate and manage treatment plans, including prescribing medications
  • Operate independent practices without a required collaborative physician agreement

The bill maintains Pennsylvania Board of Nursing authority over APRN licensure and preserves existing oversight structures for new NP graduates, who would still complete a transitional practice period before accessing full independent practice.

The 41–9 Vote and What It Signals

The Senate vote was not close. A 41–9 margin across a chamber that has historically been resistant to NP scope expansion signals meaningful bipartisan movement on this issue. Pennsylvania medical associations have long opposed full-practice authority legislation, citing patient safety concerns and the role of physician oversight in complex cases. Those objections did not prevent passage this time, though organized medicine is expected to be active in the House debate.

The Pennsylvania Coalition of Nurse Practitioners has framed SB717 primarily as a access-to-care bill. Pennsylvania has significant rural nursing shortages, particularly in the western and north-central parts of the state, where physician supply is limited and NPs represent a practical care delivery solution. The current collaborative agreement requirement functions as a geographic access problem in those communities: if a physician collaborative partner is unavailable or unwilling to sign an agreement, an NP cannot practice—regardless of their clinical qualifications.

Clinical context from the author

I did my travel nursing rotations through western Pennsylvania rural hospitals twice. In those markets, the collaborative agreement requirement is not a safety structure—it is a scheduling constraint. NPs are qualified clinicians. The 41 Senate votes are the correct read of what actually happens in rural Pennsylvania hospital wings.

What Happens Next

SB717 now heads to the Pennsylvania House of Representatives. No House vote date had been scheduled as of publication. The legislative calendar for the remainder of the 2026 session will determine whether the bill advances before the session ends. If the House passes an amended version of the bill, the legislation would return to the Senate for a concurrence vote before going to the governor for signature.

Pennsylvania Governor Josh Shapiro has not made a formal public statement on SB717. His administration has broadly supported healthcare access expansion measures, which observers interpret as an indicator of potential receptivity, though gubernatorial positions on specific APRN scope bills vary and no commitment should be assumed from general healthcare platform language.

Impact on Pennsylvania Nurses and NPs

If SB717 becomes law, Pennsylvania would join the 30+ states that have enacted full or substantially reduced-oversight practice authority for nurse practitioners. The practical effects for Pennsylvania NPs would include:

  • Ability to open independent NP clinics without requiring a physician partner on agreement—a significant barrier to NP entrepreneurship in PA
  • Elimination of annual collaborative agreement renewal overhead and associated administrative costs
  • Expanded prescribing flexibility, particularly in rural and underserved areas where physician collaborative partners have been difficult to secure
  • Potential upward pressure on NP salaries as NPs gain additional leverage and independent practice becomes viable—Pennsylvania NPs currently average $97,400 (BLS OEWS May 2025), below the national NP mean of $137,300, partly reflecting the current scope constraints